Myeloid cells are considered to be devoid of the prime SARS-CoV-2 receptor ACE2 (16, 18, 20, 36, 46–48, 51), and initially, in vitro infection experiments provided contrasting results whether and how these cells are infected. This evidence concerns the gene ACE2 and infection.